Entity family

Browse funders

Organisations named as supporting, sponsoring, or funding research. Examples include Wellcome, NIHR, research councils.

2articles mentioning funders

2funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: Teclison, Inc. ×

Teclison, Inc.

This funder is selected. Its supporting articles are shown below.

Teclison, Inc.2

Articles mentioning Teclison, Inc.

2 articles · page 1 of 1

492 Phase 2 single-arm study of trans-arterial tirapazamine embolization (TATE) plus pembrolizumab for liver metastatic colorectal cancer who have progressed on at least two lines of chemotherapy

jitc · abstract · 2025-11-04 · 1 matching annotations

84.2%

Teclison, Inc.pembrolizumab Colorectal cancer pembro UC Irvine Medical Center mCRC-MSS China Medical University Triservice General Hospital

… of care chemotherapy.Acknowledgements Funding was supported by Teclison, Inc.Trial Registration NCT03259867, NCT04701476Ethics Approval Ethic…

594 Tumor necrosis-induced expansion of anti-tumor T cells enhanced the efficacy of immune checkpoint inhibitors (ICIs) and salvaged patients with immunotherapy-refractory cancers

jitc · abstract · 2025-11-04 · 1 matching annotations

87.7%

Teclison, Inc.gastric cancer NSCLC HCC Chang-Gung Memorial Linkou Hospital TATE ICI immunotherapy

…cy of expanded T cells.Acknowledgements Funding was provided by Teclison, Inc.Trial Registration NCT03259867, NCT04701476Ethics Approval UCI #…